Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)
China · Delayed Price · Currency is CNY 20.75
-0.08 (-0.38%)
At close: Jun 18, 2026
SHE:300970 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 218.62 | 110.27 | -47.57 | 30.35 | 78.25 | 15.5 |
Depreciation & Amortization | 199.37 | 199.37 | 167.98 | 133.58 | 98.99 | 84.49 |
Other Amortization | 0.65 | 0.65 | 0.23 | 0.27 | 0.26 | 0.02 |
Loss (Gain) From Sale of Assets | 2.15 | 2.15 | 1.48 | 10.89 | 1.33 | 0.26 |
Asset Writedown & Restructuring Costs | 0.67 | 0.67 | 0.4 | -0.09 | 0.36 | 0.65 |
Loss (Gain) From Sale of Investments | - | - | -0.09 | -0.37 | -4.2 | -2.25 |
Other Operating Activities | 23.52 | 24.69 | 26.1 | 13.23 | 5.43 | 4.61 |
Change in Accounts Receivable | 3.3 | 3.3 | -0.19 | -5.27 | 20.71 | -22.5 |
Change in Inventory | -28.93 | -28.93 | -15.18 | -31.12 | -52.48 | -24.1 |
Change in Accounts Payable | 33.06 | 33.06 | 2.72 | 12.84 | 30.61 | 26.39 |
Change in Other Net Operating Assets | 0.08 | 0.08 | 1.91 | 2.36 | 0.6 | - |
Operating Cash Flow | 452.49 | 345.31 | 137.8 | 166.67 | 179.84 | 83.08 |
Operating Cash Flow Growth | 220.37% | 150.59% | -17.32% | -7.32% | 116.46% | -58.27% |
Capital Expenditures | -122.11 | -123.12 | -268.22 | -224.15 | -407.91 | -204.09 |
Sale of Property, Plant & Equipment | 0.11 | 0.09 | 0.06 | 1.34 | 0.13 | - |
Investment in Securities | - | - | - | 99.7 | 398.12 | -441.64 |
Other Investing Activities | - | - | -0.08 | 0.54 | 4.37 | 2.02 |
Investing Cash Flow | -122 | -123.03 | -268.24 | -122.58 | -5.29 | -643.72 |
Long-Term Debt Issued | - | 149.47 | 251.03 | 75.26 | 141.7 | 169.66 |
Long-Term Debt Repaid | - | -155.53 | -135.46 | -129.56 | -157.07 | -55.78 |
Net Debt Issued (Repaid) | -7.36 | -6.06 | 115.57 | -54.3 | -15.37 | 113.88 |
Issuance of Common Stock | 25.76 | 25.76 | 24.66 | 16.96 | - | 609.28 |
Repurchase of Common Stock | - | - | -30.01 | - | - | - |
Common Dividends Paid | -11.65 | -11.54 | -33.55 | -35.55 | -2.69 | -35.77 |
Other Financing Activities | -13.76 | -1.38 | 4.01 | 6.5 | 4.1 | -7.69 |
Financing Cash Flow | -7 | 6.78 | 80.67 | -66.39 | -13.97 | 679.7 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | 0 |
Net Cash Flow | 323.49 | 229.06 | -49.77 | -22.3 | 160.59 | 119.07 |
Free Cash Flow | 330.38 | 222.19 | -130.42 | -57.48 | -228.07 | -121.01 |
Free Cash Flow Margin | 23.02% | 17.20% | -12.64% | -5.77% | -30.34% | -20.93% |
Free Cash Flow Per Share | 2.31 | 1.44 | -0.86 | -0.38 | -1.50 | -0.84 |
Cash Income Tax Paid | 0.91 | 0.85 | 0.9 | 1.36 | 2.61 | 0.2 |
Levered Free Cash Flow | 196.9 | 131.86 | -106.77 | -48.42 | -255.83 | -174.72 |
Unlevered Free Cash Flow | 205.73 | 141.84 | -99.78 | -42.96 | -254.15 | -172.32 |
Change in Working Capital | 7.52 | 7.52 | -10.74 | -21.2 | -0.57 | -20.2 |